Ashima Makol Selected Research

Rheumatoid Vasculitis

1/2020	Rituximab Therapy for Systemic Rheumatoid Vasculitis: Indications, Outcomes, and Adverse Events.
1/2015	Rheumatoid vasculitis: an update.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ashima Makol Research Topics

Disease

8	Vasculitis (Vasculitides) 01/2021 - 04/2011
8	Rheumatoid Arthritis 10/2018 - 10/2008
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2019 - 04/2011
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 01/2017
2	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2021 - 11/2019
2	Rheumatoid Vasculitis 01/2020 - 01/2015
2	Hypertension (High Blood Pressure) 11/2017 - 02/2016
2	Arthritis (Polyarthritis) 03/2012 - 01/2010
2	Necrosis 10/2011 - 01/2010
2	Inflammation (Inflammations) 10/2011 - 01/2011
1	Dermatomyositis (Dermatopolymyositis) 01/2022
1	Lupus Nephritis 01/2022
1	COVID-19 01/2022
1	Gastroparesis 01/2022
1	Vomiting 01/2022
1	Nausea 01/2022
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2022
1	Infections 01/2022
1	Pericarditis 01/2021
1	Pleurisy (Pleuritis) 01/2021
1	Churg-Strauss Syndrome (Allergic Angiitis) 01/2021
1	Kidney Diseases (Kidney Disease) 11/2020
1	Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction) 01/2020
1	Glomerulonephritis 11/2019
1	Diffuse Scleroderma (Progressive Systemic Sclerosis) 11/2019
1	Uveitis 01/2018
1	Scleritis (Episcleritis) 01/2018
1	Purine Nucleoside Phosphorylase Deficiency 12/2017
1	Systemic Scleroderma (Systemic Sclerosis) 11/2017
1	Localized Scleroderma (Morphea) 11/2017
1	Atherosclerotic Plaque (Atheroma) 11/2016
1	Aneurysm (Aneurysms) 11/2016
1	Cerebral Infarction 11/2016
1	Ruptured Aneurysm 11/2016
1	Dyslipidemias (Dyslipidemia) 02/2016
1	Takayasu Arteritis (Arteritis, Takayasu's) 02/2016
1	Brain Stem Infarctions (Weber Syndrome) 05/2015
1	Ischemic Stroke 05/2015
1	Stroke (Strokes) 05/2015
1	Polyarteritis Nodosa (Periarteritis Nodosa) 05/2015
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 05/2014
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 05/2014
1	Chronic Disease (Chronic Diseases) 11/2012
1	Fever (Fevers) 03/2012
1	Exanthema (Rash) 03/2012
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 03/2012
1	Autoimmune Diseases (Autoimmune Disease) 03/2012
1	Skin Manifestations 03/2012
1	Histoplasmosis 12/2011
1	Arthralgia (Joint Pain) 10/2011
1	Rare Diseases (Rare Disease) 06/2011
1	Autoimmune Pancreatitis 06/2011

Drug/Important Bio-Agent (IBA)

3	Interferon Type IIBA 01/2022 - 12/2017
3	AutoantibodiesIBA 01/2021 - 01/2010
3	Rituximab (Mabthera)FDA Link 11/2020 - 10/2011
3	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 11/2020 - 04/2011
3	GlucocorticoidsIBA 03/2019 - 10/2014
3	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2016 - 06/2011
2	Antinuclear AntibodiesIBA 01/2022 - 01/2010
2	Phenobarbital (Luminal)FDA Link 01/2020 - 11/2016
2	Biological ProductsIBA 01/2018 - 01/2015
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2017 - 03/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2012 - 10/2008
2	tocilizumab (atlizumab)FDA Link 03/2012 - 10/2011
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 03/2012 - 10/2011
2	Etanercept (Enbrel)FDA Link 03/2012 - 01/2010
2	Immunoglobulins (Immunoglobulin)IBA 06/2011 - 01/2011
2	Antiphospholipid AntibodiesIBA 02/2010 - 01/2010
1	IFIH1 Interferon-Induced HelicaseIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	dimemorfan (AT 17)IBA 01/2022
1	goblet cell silencer inhibitorIBA 01/2022
1	VaccinesIBA 01/2022
1	Myeloblastin (Proteinase 3)IBA 11/2019
1	Peroxidase (Myeloperoxidase)IBA 11/2019
1	Adenosine (Adenocard)FDA LinkGeneric 12/2017
1	HypoxanthineIBA 12/2017
1	RNA Polymerase IIIIBA 11/2017
1	LipidsIBA 11/2017
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2017
1	Dihydrotachysterol (AT 10)IBA 01/2017
1	Minocycline (Cyclops)FDA LinkGeneric 05/2015
1	Pharmaceutical PreparationsIBA 05/2015
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2015
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2014
1	Prednisolone (Predate)FDA LinkGeneric 11/2012
1	Interleukin-6 (Interleukin 6)IBA 03/2012
1	Antimalarials (Antimalarial Agents)IBA 03/2012
1	Intravenous Immunoglobulins (IVIG)FDA Link 03/2012
1	Methotrexate (Mexate)FDA LinkGeneric 03/2012
1	Azathioprine (Imuran)FDA LinkGeneric 12/2011
1	Abatacept (Orencia)FDA Link 10/2011

Therapy/Procedure

10	Therapeutics 01/2020 - 10/2008
1	Plasma Exchange 11/2020
1	Length of Stay 03/2019
1	Orthopedic Procedures 10/2018
1	Vascular Surgical Procedures 02/2016
1	Endovascular Procedures 02/2016
1	Biological Therapy 01/2015
1	Duration of Therapy 08/2012